ArticleMetabolism open2020

Low dose of sodium-glucose transporter 2 inhibitor ipragliflozin attenuated renal dysfunction and interstitial fibrosis in adenine-induced chronic kidney disease in mice without diabetes.

Mayumi Yamato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.